We recently reported that deletion-type copy number variations of the T cell receptor (TCR) γ, α, and δ genes greatly enhanced susceptibility to multiple sclerosis (MS). However, the effect of abnormal TCR γδ gene rearrangement on MS pathogenesis remains unknown. In the present study, we aimed to clarify γδ TCR repertoire alterations and their relationship to clinical and immunological parameters in MS patients by comprehensive flow cytometric immunophenotyping. Peripheral blood mononuclear cells obtained from 30 untreated MS patients in remission and 23 age-and sex-matched healthy controls (HCs) were stained for surface markers and intracellular cytokines after stimulation with phorbol 12-myristate 13-acetate and ionomycin, and analyzed by flow cytometry. MS patients showed significantly decreased percentages of Vδ2 + CD127 low/− cells in CD4 + T cells (r = 0.7826, p < 0.0001; and r = 0.7848, p < 0.0001, respectively), whereas such correlations were totally absent in MS patients. These findings suggest that decreased Vδ2 + Vγ9 + γδ T cells are associated with disability in MS. Therefore, the Vδ1/Vδ2 ratio might be a candidate biomarker for predicting disease severity in MS.
We recently reported that deletion-type copy number variations of the T cell receptor (TCR) γ, α, and δ genes greatly enhanced susceptibility to multiple sclerosis (MS). However, the effect of abnormal TCR γδ gene rearrangement on MS pathogenesis remains unknown. In the present study, we aimed to clarify γδ TCR repertoire alterations and their relationship to clinical and immunological parameters in MS patients by comprehensive flow cytometric immunophenotyping. Peripheral blood mononuclear cells obtained from 30 untreated MS patients in remission and 23 age-and sex-matched healthy controls (HCs) were stained for surface markers and intracellular cytokines after stimulation with phorbol 12-myristate 13-acetate and ionomycin, and analyzed by flow cytometry. MS patients showed significantly decreased percentages of Vδ2 + CD127 low/− cells in CD4 + T cells (r = 0.7826, p < 0.0001; and r = 0.7848, p < 0.0001, respectively), whereas such correlations were totally absent in MS patients. These findings suggest that decreased Vδ2 + Vγ9 + γδ T cells are associated with disability in MS. Therefore, the Vδ1/Vδ2 ratio might be a candidate biomarker for predicting disease severity in MS. γδ T cells express TCR γ and δ chains and are a distinct line age of cells from αβ T cells, comprising 1-5% of lymphocytes in peripheral blood (5) . These unconventional T cells respond quickly to specific pathogenassociated molecular patterns (6) (7) (8) . Thus, γδ T cells play an important role in the early phase of host defense against bacteria (6), mycobacteria (7), and fungi (8) . γδ T cells expressing various effector and regula tory molecules produce a variety of pro and antiinflammatory cytokines (9-11). As a result, these cells are involved in the pathogenesis of various inflammatory diseases (12) . For example, γδ T cells infiltrate CNS tissues at the earliest phase of EAE. By innately producing IL17 upon stimulation with IL1β and IL23, γδ T cells amplify Th17 autoimmune responses (13) .
In MS, total γδ T cells are enriched in both the blood and cerebrospinal fluid while a fraction of CD161 high
CCR6
+ γδ T cells are increased in the cerebrospinal fluid at relapse (14) . Notably, γδ T cells are reported to be abundantly present in chronic active brain lesions (15) (16) (17) (18) . However, such γδ T cells possess limited diversity (18) . Importantly, γδ T cells can lyse human brainderived oligodendrocytes via the recognition of heat shock proteins (18, 19) . We recently reported findings of a genomewide copy number variation (CNV) association study where deletion type CNVs at TCRα and γ loci greatly enhanced susceptibility to MS (20) . Given that deletiontype CNV at the TCRα locus also covers TCRδ genes (5), we hypothesized that a deviation in TCRγδ gene rearrangement contributes to the pathogenesis of MS. Only two previous reports have described an increase of peripheral blood Vδ1 + γδ T cells in Caucasian MS patients (21, 22) ; however, neither study directly measured Vδ2 + γδ T cells. No previous studies have reported the peripheral blood Vδ and Vγ repertoires in MS, nor their relationship with αβ T cells. Therefore, the present study investigated alterations of γδ T cell subsets in the context of the TCR γδ repertoire in untreated MS patients by comprehensive flow cytometric immunophenotyp ing. Furthermore, we aimed to clarify the relationship between γδ T cell alterations and clinicoimmunological parameters.
MaTerials anD MeThODs study Participants
Study participants were 30 untreated MS patients and 23 healthy controls (HCs) ( Table 1 ). All patients were thoroughly examined and regularly followedup at a single MS center in Kyushu University Hospital. The diagnosis of MS was based on established criteria (23) . MS patients, who were in remission, negative for antiaquaporin 4 antibodies (24, 25), and not receiv ing corticosteroids or any diseasemodifying therapies (DMTs) at least 6 months prior to the immunophenotyping, were enrolled between March 1 2016 and February 28 2017. The frequency of females and age at examination did not significantly differ between the two study groups. The study was approved by the Ethical Committee of Kyushu University, and conducted with written informed consent from all participants in accordance with the World Medical Association Declaration of Helsinki.
antibodies and Flow cytometric analysis
Peripheral blood mononuclear cells were collected by density gradient centrifugation using Lymphoprep tubes (AXISSHIELD Poc AS, Oslo, Norway) containing FicollPaque (GE Healthcare, Little Chalfont, UK) and then suspended in RPMI1640 medium (Wako, Osaka, Japan) supplemented with 10% fetal bovine serum (Gibco, Waltham, MA, USA). Immunophenotyping was performed using the antibodies shown in Tables S1 and S2 + to Vδ2 + γδ T cells (Vδ1/Vδ2 ratio) and found that MS patients had a significantly higher Vδ1/ Vδ2 ratio than HCs (mean ± SD, 11.05 ± 29.56 vs. 0.80 ± 1.26, p = 0.0033) ( Figure 1D ).
altered cytokine Production by γδ T cells in Ms Patients
Regarding cytokine production by γδ T cells, 
αβ T cell subpopulations in Ms Patients
There was no significant difference in the percentages of Tnaïve, Tcm, Tem, Teff, and activated T cells in the CD4 + and CD8 + T cell populations between MS patients in remission and HCs ( 
b cell subpopulations in Ms Patients
The percentages of naïve, total memory, CS + memory, transitional B cells, and plasmablasts in total B cells did not significantly differ between MS patients in remission and HCs (Table 6) . However, the percentages of CS − memory B cells was slightly but significantly decreased in MS patients compared with HCs (p corr = 0.0204).
correlation of altered γδ T cell repertoires With Disease severity in Ms Patients
To elucidate the clinical relevance of an altered γδ T cell reper toire in MS, potential correlations of γδ T cell subpopulations with the clinical demographics of MS patients were analyzed. There was no significant correlation of any γδ T cell parameter with age at disease onset, disease duration, or annualized relapse rates (data not shown). However, the percentages of Vδ2 (Figures 2A-F) . As a result, the Vδ1/Vδ2 ratio was positively correlated with both EDSS scores and MSSS (r = 0.5100, p = 0.0040; and r = 0.4875, p = 0.0063, respectively) (Figures 2G,H) . Subsequently, the cor relation of cytokineproducing γδ T cells and clinical parameters in MS patients were also analyzed. The percentages of IL17
+ IFNγ + cells in Vδ2 + or total γδ T cells did not correlate with age at disease onset, disease duration, annual ized relapse rate, EDSS score or MSSS in MS patients (data not shown). These findings were reproduced even when patients were limited to relapsingremitting MS cases (data not shown).
correlations of altered γδ T cell repertoires With regulatory T cells in Ms Patients
Finally, potential correlations of γδ T cell repertoires with αβ T cell and B cell subpopulations were also analyzed in MS patients and HCs. No significant association of γδ T cell subpopulations with any αβ T cell or B cell subpopulation was found in MS patients + T cells (r = 0.7826, p < 0.0001; and r = 0.7848, p < 0.0001, respectively) (Figures 3A,C) . The same was also observed for γδ T cell percentages in total CD3 + T cells (r = 0.4829, p = 0.0196). The percentages of Vδ2 (Figures 3E,G) . The percentages of Vδ1 + in γδ T cells and the Vδ1/Vδ2 ratio had significant negative cor relations with Treg cell percentages in CD4 + T cells (r = −0.5504, p = 0.0065; and r = −0.6031, p = 0.0023, respectively) ( Figure 3I) . By contrast, such correlations were totally lost in MS patients (Figures 3B,D,F,H,J) .
DiscUssiOn
The present study is the first to report the following characteristic features of γδ T cells in MS: (1) Two previous studies reported an increase of Vδ1 + T cells in MS (21, 22) , which is partly in accord with the increased Vδ1/ Vδ2 ratios evident in our MS cohort. However, neither study specified the disease phase of the MS patients nor examined the relationship of γδ T cells with other immune cell popula tions measured simultaneously. In the two previous studies, Zeine et al. (21) (5), recognize phosphorylated antigens of microbes, such as mycobacterium, and function in host defense by producing proinflammatory cytokines, including tumor necrosis factorα, IL17, and IFNγ (5, 9, 10). There is also increasing evidence for the regulatory functions of γδ T cells.
Vδ2
+ γδ T cells were reported to express FoxP3 and regulate the proliferation of αβ T cells (30) , producing antiinflammatory cytokines, such as transforming growth factorβ (31, 32) . Furthermore, IFNγproducing γδ T cells suppressed Th17 cell responses in murine pulmonary fibrosis models (33) + T cells was found in HCs, whereas such a correlation was completely missing in our untreated MS patients. In MS, Treg cell dysfunction has been repeatedly reported (34) (35) (36) ; however, the mechanism by which Treg cell numbers are normally controlled and how regulatory function is impaired in MS are still ill defined. Thus, to the best of our knowledge, our study is the first to demonstrate a close association between Treg cell populations and a specific γδ T cell subset, i.e., Vδ2
+ γδ T cells, in healthy humans. Although such a correlation has not been established in experimental animals, it was reported that a murine auto immune keratitis model using TCRδ knockout mice had few peripheral blood CD4 Another major γδ T cell subset is Vδ1 + γδ T cells that recognize selflipid antigens presented by CD1d molecules on antigenpresenting cells, such as dendritic cells (38) . Recently, several studies revealed that Vδ1 + γδ T cells reacted to sulfatide, a glycosphingolipid antigen abundantly present in the myelin sheath (39) (40) (41) . Thus, the increase of Vδ1 + γδ T cells in periph eral blood from MS patients from different races observed by two previous studies (21, 22 ) and the present study may account for the prominence of Vδ1 + γδ T cells in MS lesions. Collectively, the decrease of Vδ2 + γδ T cells may dampen the immunoregulatory functions of γδ T cells in peripheral blood, while the increase of Vδ1 + γδ T cells may enhance tissue dam age in MS lesions in the CNS. As a result, the Vδ1/Vδ2 ratio is closely associated with disease severity in MS, suggesting that the Vδ1/Vδ2 ratio might be a candidate biomarker for predict ing disease severity in MS.
There were several limitations to the present study. First, the sample size was relatively small due to the rarity of MS in Asians (42) and the enrollment of MS patients not on DMTs. Therefore, we analyzed our data using Bonferroni-Dunn's cor rection for multiple comparisons to minimize errors derived from sample size. Second, a comparison of the immunoprofile between patients in the relapse and remission phases was lack ing. Thus, our results should be confirmed by studies using larger numbers of MS patients in both relapse and remission phases in the future. Third, we did not measure the suppressive activ ity of the CD4 + T cells and Treg cell percentages in CD4 + T cells should be regarded as preliminary. Fourth, we did not measure the suppressive activity of γδ T cells on αβ T cells. Functional assays of γδ T cells should be performed in a future study to clarify the interaction between Vδ2 + γδ T cells and Treg cells. Finally, it has repeatedly been reported that MS phenotypes differ among races. Although an increase of Vδ1 + γδ T cell numbers is commonly found in Caucasian and Japanese MS populations, our findings regarding Vδ2 + γδ T cells should be confirmed in other races.
In conclusion, our study suggests that untreated MS patients have alterations in γδ T cells even in the remission phase. Specifically, decreased numbers of Vδ2
+

Vγ9
+ and IFNγ + Vδ2 + cells and a relative increase of Vδ1 + cells may, respectively, con tribute to MS severity. We propose that the Vδ1/Vδ2 ratio may be a novel biomarker for disease severity in MS.
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